Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Peripheral T Cell Lymphoma”

522 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 522 results

Large-scale testing (Phase 3)Looking for participantsNCT06776952
What this trial is testing

A Randomized, Double-blind, Multicenter Phase III Study of XNW5004 Tablets in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Relapsed/Refractory Peripheral T Cell Lymphoma
Evopoint Biosciences Inc. 120
Testing effectiveness (Phase 2)Ended earlyNCT05883449
What this trial is testing

Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma
Affimed GmbH 25
Large-scale testing (Phase 3)Study completedNCT00003938
What this trial is testing

Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients

Who this might be right for
Cancer
European Organisation for Research and Treatment of Cancer - EORTC 115
Testing effectiveness (Phase 2)UnknownNCT05559008
What this trial is testing

A Umbrella Study in R/R PTCL Guided by Molecular Subtypes

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 116
Testing effectiveness (Phase 2)WithdrawnNCT01652014
What this trial is testing

Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in Remission+51 more
University of Medicine and Dentistry of New Jersey
Early research (Phase 1)Study completedNCT00005092
What this trial is testing

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
M.D. Anderson Cancer Center 7
Testing effectiveness (Phase 2)UnknownNCT05495100
What this trial is testing

A Single-arm, Multicenter, Prospective Clinical Study of Mitoxantrone Liposome Combined With Chidamide and Azacitidine in the Treatment of Relapsed and Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University 45
Early research (Phase 1)Study completedNCT00042900
What this trial is testing

Pyroxamide in Treating Patients With Advanced Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01044745
What this trial is testing

Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+108 more
University of Nebraska 20
Testing effectiveness (Phase 2)Study completedNCT00865969
What this trial is testing

Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Spectrum Pharmaceuticals, Inc 129
Early research (Phase 1)UnknownNCT04008394
What this trial is testing

Anti-CD30 CAR-T Therapy in Patients With Refractory/Relapsed Lymphocyte Malignancies

Who this might be right for
Adult T-Cell Lymphoma/LeukaemiaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+3 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 50
Testing effectiveness (Phase 2)UnknownNCT06037239
What this trial is testing

Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study

Who this might be right for
Cutaneous T-cell Lymphoma
Peking Union Medical College Hospital 53
Testing effectiveness (Phase 2)UnknownNCT04994210
What this trial is testing

Sintilimab in Combination With Chidamide in Newly Diagnosed ENKTCL

Who this might be right for
Safety and Efficacy
Sun Yat-sen University 30
Early research (Phase 1)Study completedNCT05321147
What this trial is testing

Safety and Efficacy of Lacutamab in Patients With Relapsed/Refractory Peripheral T-cell Lymphoma That Express KIR3DL2

Who this might be right for
Peripheral T Cell Lymphoma
Innate Pharma 20
Testing effectiveness (Phase 2)Study completedNCT00182637
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT04405375
What this trial is testing

GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Beijing Tongren Hospital 29
Early research (Phase 1)UnknownNCT04712864
What this trial is testing

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Who this might be right for
T-Cell LymphomaPeripheral T-Cell Lymphoma RefractoryCutaneous T-Cell Lymphoma Refractory+2 more
Legend Biotech USA Inc 50
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00655668
What this trial is testing

A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lymphoma

Who this might be right for
T-cell Non-Hodgkin's Lymphoma
Celgene 54
Large-scale testing (Phase 3)WithdrawnNCT03355768
What this trial is testing

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Jennifer Amengual
Load More Results